Long‐term efficacy and safety of alemtuzumab in advanced primary cutaneous T‐cell lymphomas
暂无分享,去创建一个
J. Cayuela | P. Guitera | L. Michel | M. Bagot | I. Madelaine | M. Battistella | J. Roux | P. Brice | A. Bensussan | H. Bachelez | J. Bouaziz | A. Masson | I. Moulonguet | F. Mouly | C. Ram-Wolff